Cognitive Neurology Unit Clinical Registry

Recruiting Observational Study
Alzheimer Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
50 – 95
Sex
Any
Study type
Observational
Participants needed
500 (estimated)
Sponsor
Beth Israel Deaconess Medical Center · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

A Prospective Comparative Study Of Monoclonal Antibodies For The Treatment Of Alzheimer's Disease

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * o Patient meets clinical criteria for mild cognitive impairment or early dementia from Alzheimer's disease * Patient has evidence of cognitive impairment on neuropsychological testing * Patient has not progressed to the moderate stage of dementia based on neuropsychologic…
Contacts

Dan Z Press, MD

(617) 667-4074

dpress@bidmc.harvard.edu

CONTACT

Chun Lim, MD

(617) 667-4074

clim@bidmc.harvard.edu

CONTACT